Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-021443

Chief Executive Officer sold 5,912 shares at $16.00 ($94,592)

  • Chief Executive Officer acquired 5,912 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2023-03-24 Option exercise +170 $2.25 $383 1,701,446 D: show line 1 in the form
Harris Todd Chief Executive Officer 2023-03-24 Sale −170 $16.00 $2,720 1,701,276 D: show line 2 in the form
Harris Todd Chief Executive Officer 2023-03-27 Option exercise +2,963 $2.25 $6,667 1,704,239 D: show line 3 in the form
Harris Todd Chief Executive Officer 2023-03-27 Sale −2,963 $16.00 $47,408 1,701,276 D: show line 4 in the form
Harris Todd Chief Executive Officer 2023-03-28 Option exercise +2,779 $2.25 $6,253 1,704,055 D: show line 5 in the form
Harris Todd Chief Executive Officer 2023-03-28 Sale −2,779 $16.00 $44,464 1,701,276 D: show line 6 in the form
Open-market sales · 5,912 sh · avg $16.00 · $94,592

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2023-03-24 Option exercise · Stock Option (Right to Buy) −170 409,606 D: show line 7 in the form
Harris Todd Chief Executive Officer 2023-03-27 Option exercise · Stock Option (Right to Buy) −2,963 406,643 D: show line 8 in the form
Harris Todd Chief Executive Officer 2023-03-28 Option exercise · Stock Option (Right to Buy) −2,779 403,864 D: show line 9 in the form
Loading xslF345X04/doc4.xml…